Supported by the Major State Basic Research Development Program of China (973 program) (No. 2004CB518705, 2002CB513100-2) and Clinical Key Subject Foundation from Ministry of Health of China "Cell Cycle Diag-nosis and Analysis in Clinical Tumor (III)".
Objective: To establish a system in detecting the cell cycle specificity induced by recombinant human Fas ligand in vitro, so as to provide a reliable platform for further exploring the mechanism of cell cycle contro...